Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2021	Mar. 31, 2021
ASSETS
Cash and cash equivalents	$ 9,490	$ 8,195
Restricted cash and cash equivalents	2,697	1,957
Investments in marketable securities	4,835	4,820
Finance receivables, net of allowance for credit losses of $1,190 and $1,178	79,549	79,192
Investments in operating leases, net	37,946	37,091
Other assets	2,460	2,473
Total assets	136,977	133,728
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	111,709	109,725
Deferred income taxes	2,499	2,860
Other liabilities	5,624	5,548
Total liabilities	119,832	118,133
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2021 and March 31, 2021	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive income	15	8
Retained earnings	16,213	14,670
Total shareholder's equity	17,145	15,595
Total liabilities and shareholder's equity	$ 136,977	$ 133,728